1![pwc_master_logo_shortform pwc_master_logo_shortform](https://www.pdfsearch.io/img/49495f1a197420eaba1ad7b322f3b14a.jpg) | Add to Reading ListSource URL: annualreport.basilea.comLanguage: English - Date: 2015-03-04 10:40:28
|
---|
2![Microsoft Word - 20150424_FINAL_ECCMID_EN_with links.docx Microsoft Word - 20150424_FINAL_ECCMID_EN_with links.docx](https://www.pdfsearch.io/img/7c73ac684678cfa50e24ceaa540f52fb.jpg) | Add to Reading ListSource URL: www.basilea.comLanguage: English |
---|
3![Microsoft Word - 20150401_Basilea_In-licensing panRAF_EN.docx Microsoft Word - 20150401_Basilea_In-licensing panRAF_EN.docx](https://www.pdfsearch.io/img/bf2d1d78de6e7075813ac3f53a80f6d7.jpg) | Add to Reading ListSource URL: www.basilea.comLanguage: English |
---|
4![Microsoft Word - 20150429_Basilea_AGM15 Results_EN.docx Microsoft Word - 20150429_Basilea_AGM15 Results_EN.docx](https://www.pdfsearch.io/img/ae3d276a1443f0c07e05332fc62946b6.jpg) | Add to Reading ListSource URL: www.basilea.comLanguage: English |
---|
5![Microsoft Word - 20150504_Basilea_Start of phase 1 panRAF_EN.docx Microsoft Word - 20150504_Basilea_Start of phase 1 panRAF_EN.docx](https://www.pdfsearch.io/img/4dc404a51bfd3d2d388691622ff3a705.jpg) | Add to Reading ListSource URL: www.basilea.comLanguage: English |
---|
6![](https://www.pdfsearch.io/img/bc9fa59655d602a831d1c872b65d8c0c.jpg) | Add to Reading ListSource URL: reports.standardandpoors.comLanguage: English - Date: 2015-02-26 05:00:42
|
---|
7![PRESS RELEASE Swissmedic approves Basilea’s antibiotic Zevtera® (ceftobiprole medocaril) for the treatment of pneumonia Basel, Switzerland, December 22, 2014 – Basilea Pharmaceutica Ltd. (SIX: BSLN) reports that the PRESS RELEASE Swissmedic approves Basilea’s antibiotic Zevtera® (ceftobiprole medocaril) for the treatment of pneumonia Basel, Switzerland, December 22, 2014 – Basilea Pharmaceutica Ltd. (SIX: BSLN) reports that the](https://www.pdfsearch.io/img/554a5d6f7bfba85f808196bae1df1592.jpg) | Add to Reading ListSource URL: www.basilea.comLanguage: English |
---|
8![PRESS RELEASE Basilea announces that FDA’s Anti-Infective Drugs Advisory Committee recommends approval of isavuconazole for the treatment of invasive aspergillosis and mucormycosis Basel, Switzerland, January 22, 2015 PRESS RELEASE Basilea announces that FDA’s Anti-Infective Drugs Advisory Committee recommends approval of isavuconazole for the treatment of invasive aspergillosis and mucormycosis Basel, Switzerland, January 22, 2015](https://www.pdfsearch.io/img/b8553cd81bba38d6a9127397d04f1897.jpg) | Add to Reading ListSource URL: www.basilea.comLanguage: English |
---|
9![PRESS RELEASE Basilea’s oncology drug candidate BAL101553 shows first evidence of antitumor activity in phase 1 study Results of recently completed clinical phase 1 study presented at ASCO PRESS RELEASE Basilea’s oncology drug candidate BAL101553 shows first evidence of antitumor activity in phase 1 study Results of recently completed clinical phase 1 study presented at ASCO](https://www.pdfsearch.io/img/7225dfc3469cdf73fab47408bfe8bc3d.jpg) | Add to Reading ListSource URL: hbmpartners.comLanguage: English - Date: 2014-06-23 09:59:40
|
---|
10![Area News www.baselarea.ch News from the Basel business area April 2007 Area News www.baselarea.ch News from the Basel business area April 2007](https://www.pdfsearch.io/img/af54dc1fff441928b90489d747943b3e.jpg) | Add to Reading ListSource URL: www.baselarea.chLanguage: English - Date: 2011-03-15 04:41:31
|
---|